VIDEO - The BioAgilytix Difference - Bioanalytical Lab & Top CRO for Large Molecule Bioanalysis

VIDEO – The BioAgilytix Difference

Learn why 7 of the top 10 global pharmaceutical and biotechnology companies partner with BioAgilytix for their bioanalytical needs. BioAgilytix CEO, Jim Datin, walks through the elements that make up the “BioAgilytix Difference,” focusing on our people, technologies, and industry recognition.

Cell-Based Assays

Learn how BioAgilytix provides the specialized large molecule insight and proven GLP / GMP knowledge needed to support a full range of cell-based assay (CBA) requirements.

Pharmacokinetics & Pharmacodynamics (PK/PD)

See how our PK expertise complements our immunogenicity services by evaluating absorption, distribution, metabolism and excretion characteristics of a product.

Case Studies

Learn why we’re a trusted partner to 22 of the top 25 global pharma and biotech companies.

Tell Us About Your Project

What are your specific assay needs? Let’s schedule a conversation to review your
questions and requirements with one of our scientists.

SPEAK TO A SCIENTIST

Featured Expert

Todd Lester, Associate Director

Dr. Steven Michael, Senior Vice President and Chief Operating Officer

Dr. Steven Michael

Dr. Nathan Rudemiller, Manager II

Dr. Nathan Rudemiller

Dr. Michelle Miller, Manager II

Dr. Michelle Miller

Dr. Marianne Scheel Fjording, Scientific Officer

Dr. Marianne Scheel Fjording

Luke Armstrong, Manager II

Dr. Linda Robbie, Vice President and General Manager, Boston Operations

Dr. Linda Robbie

Laura Lassen, Director

Krystal Alligood, Associate Director

Krystal Alligood

Kathryn Lindley, Vice President, Operations

Kathryn Lindley

Dr. Jim McNally, Chief Scientific Officer

Dr. Jim McNally

Jessica Weaver, Manager II & Bioanalytical Project Manager

Dr. Jennifer Zemo, Director

Dr. Jennifer Zemo

Jennifer Johnson, Manager I

Jennifer Johnson

Dr. Janina Hajek, Principal Investigator

Dr. Janina Hajek

Dr. Janett Schwarz, Principal Investigator

Dr. Janett Schwarz

Dr. Imke Müller, Director, Principal Investigator

Dr. Imke Müller

Dr. Frank Wischnewski, Associate Director

Dr. Frank Wischnewski

Dr. Frank Horling, General Manager, Europe

Dr. Frank Horling

Dr. Florian Unger, Principal Investigator

Dr. Florian Unger

Dr. Florian Anlauff, Principal Investigator

Dr. Florian Anlauff

David Rusnak, Director, Bioanalytical Operations

Dave Williams, Vice President, Bioanalytical Operations

Dr. Daniel Worms, Associate Principal Investigator

Dr. Daniel Worms

Dr. Chad Briscoe, Vice President, Business Development Europe

Dr. Chad Briscoe

Carla Mejia, Manager II

Carla Gibbons, Senior QA Director

Dr. Anne Timmerman, Associate Principal Investigator

Dr. Anne Timmerman

Anita Simkins, Senior Vice President, Global Quality Assurance

Amanda Hays, Scientific Officer

Dr. Afshin Safavi, Founder & Board Member

Dr. Afshin Safavi

Cell-Based Assays

Learn how BioAgilytix provides the specialized large molecule insight and proven GLP / GMP knowledge needed to support a full range of cell-based assay (CBA) requirements.

Pharmacokinetics & Pharmacodynamics (PK/PD)

See how our PK expertise complements our immunogenicity services by evaluating absorption, distribution, metabolism and excretion characteristics of a product.

Case Studies

Learn why we’re a trusted partner to 22 of the top 25 global pharma and biotech companies.

Tell Us About Your Project

What are your specific assay needs? Let’s schedule a conversation to review your
questions and requirements with one of our scientists.

SPEAK TO A SCIENTIST

USA Headquarters

2300 Englert Dr

Durham, NC, 27713

919-381-6097

European Headquarters

Lademannbogen 10

22339 Hamburg Germany

+49 40 526779 0

Boston Laboratory

1320 Soldiers Field Road

Boston, MA, 02135

617-456-0700

[email protected]

[email protected]